Core Scientific price target raised to $26 from $18 at Cantor Fitzgerald

Cantor Fitzgerald analyst Brett Knoblauch raised the firm’s price target on Core Scientific (CORZ) to $26 from $18 and keeps an Overweight rating on the shares. With shareholders set to vote on the proposed acquisition by CoreWeave (CRWV), the firm sees two scenarios should the acquisition get voted down: CoreWeave comes back to the table or Core Scientific continues down the HPC path solo. In either case, it still sees “attractive risk/reward,” the analyst tells investors.